MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Начало・Списък с акции・Quest Diagnostics Inc

Quest Diagnostics Inc

Затворен

СекторЗдравеопазване

189.48 1.55

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

189.07

Максимум

189.97

Ключови измерители
By Trading Economics
Приходи	61M 296M
Продажби	109M 2.8B
P/E Средно за сектора	21.89 36.442
Дивидентна доходност	1.68
Марж на печалбата	10.721
Служители	55,000
EBITDA	-37M 451M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+2.11% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	1.68% 3.00%
Следващи печалби	21.10.2025 г.
Следваща дата на дивидент	20.10.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	1.9B 20B
Предишно отваряне	187.93
Предишно затваряне	189.48

Настроения в новините

By Acuity

37%

63%

97 / 371 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

175.87 / 176.5 Подкрепа & съпротива

Quest Diagnostics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

17.10.2025 г., 18:13 ч. UTC

Значими двигатели на пазара

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17.10.2025 г., 17:05 ч. UTC

Значими двигатели на пазара

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

18.10.2025 г., 13:30 ч. UTC

Придобивния, сливания и поглъщания

Deal Expected to Value Unit at Roughly $4B, Sources Say -- WSJ

18.10.2025 г., 13:30 ч. UTC

Придобивния, сливания и поглъщания

Deal Could Be Announced as Soon as Next Week, Sources Say -- WSJ

18.10.2025 г., 13:30 ч. UTC

Придобивния, сливания и поглъщания

Gucci Owner Kering Nears $4 Billion Sale of Beauty Unit to L'Oréal -- WSJ

18.10.2025 г., 13:30 ч. UTC

Придобивния, сливания и поглъщания

Gucci Parent Kering in Talks to Sell Beauty Business to L'Oréal, Sources Say -- WSJ

18.10.2025 г., 08:20 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

18.10.2025 г., 07:00 ч. UTC

Печалби

A Growing Nimby Movement Could Upend the Data Center Boom -- Barrons.com

17.10.2025 г., 23:25 ч. UTC

Придобивния, сливания и поглъщания

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17.10.2025 г., 22:15 ч. UTC

Пазарно говорене

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17.10.2025 г., 21:15 ч. UTC

Пазарно говорене

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17.10.2025 г., 21:07 ч. UTC

Пазарно говорене

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17.10.2025 г., 21:07 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

17.10.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

17.10.2025 г., 20:34 ч. UTC

Пазарно говорене

Deere Is Reaching the End of Its Downcycle -- Market Talk

17.10.2025 г., 20:27 ч. UTC

Пазарно говорене

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17.10.2025 г., 19:46 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17.10.2025 г., 19:45 ч. UTC

Пазарно говорене

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17.10.2025 г., 18:45 ч. UTC

Пазарно говорене

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17.10.2025 г., 17:51 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

17.10.2025 г., 17:51 ч. UTC

Пазарно говорене

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17.10.2025 г., 17:44 ч. UTC

Пазарно говорене

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17.10.2025 г., 17:35 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17.10.2025 г., 16:20 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

17.10.2025 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

17.10.2025 г., 16:14 ч. UTC

Пазарно говорене

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17.10.2025 г., 16:04 ч. UTC

Пазарно говорене

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17.10.2025 г., 15:58 ч. UTC

Пазарно говорене

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17.10.2025 г., 15:56 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17.10.2025 г., 15:43 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Quest Diagnostics Inc Прогноза

Ценова цел

By TipRanks

2.11% нагоре

12-месечна прогноза

Среден 193.5 USD 2.11%

Висок 210 USD

Нисък 178 USD

Според 13 анализатори от Wall Street, предложили 12-месечна ценова цел за Quest Diagnostics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

13 ratings

Купи

Задържане

Продай

Според 13 анализатори, дали борсови рейтинги на Quest Diagnostics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

175.87 / 176.5Подкрепа & съпротива

Recent bullish events outweigh bearish events.

All events are bullish.

Настроение

By Acuity

97 / 371 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Quest Diagnostics Inc

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.